Home
/ IBCC
/ Competitors

IBCC Competitors and Similar CompaniesClear all

IBCC's competitors and similar companies include Laboratorio Reig Jofre, Green-Swan Pharmaceuticals, Samil Pharmaceutical and Master Pharm.

	IBCC IBCC is a pharmaceutical company that manufactures medicinal products, medical devices and food supplements, and consulting.	Laboratorio Reig Jofre Laboratorio Reig Jofre researches, develops, manufactures, markets, and sells medicines and nutritional supplements.	Green-Swan Pharmaceuticals Green-Swan Pharmaceuticals is a company that manufactures and distributes drugs, medical devices, and dietary supplements.	Samil Pharmaceutical Samil Pharmaceutical (삼일제약주) is a manufacturer and supplier of medical devices and pharmaceutical products.	Master Pharm Master Pharm (formerly known as Master Pharm Poland) is a manufacturer of pharmaceutical products.
Founding Date	Founding Date 1991	Founding Date 1929	Founding Date 1997	Founding Date 1947	Founding Date 2002
Type	Type Private	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare drug development medical devices pharma supplements	Tags Healthcare cosmetics drug development medical devices pharma supplements	Tags Healthcare distribution drug development medical devices pharma supplements	Tags Healthcare distribution drug development medical devices pharma supplements	Tags Healthcare cosmetics drug development medical devices pharma supplements
Locations	Locations Rijeka, HR HQ Zürich, CH	Locations Sant Joan Despí, ES HQ Bruxelles, BE Monaco, MC Warszawa, PL Oeiras, PT Singapore, SG Madrid, ES see more	Locations CZ HQ	Locations KR HQ	Locations HQ
Employees	Employees 11	Employees 1,331	Employees 72	Employees 586	Employees N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €331.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₩219.7b (FY, 2024)	Revenue (est.) zł76.7m (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods €137.1m (FY, 2025)	Cost of goods N/A	Cost of goods ₩138.8b (FY, 2024)	Cost of goods zł45m (FY, 2021)
Gross profit	Gross profit N/A	Gross profit €208.2m (FY, 2025)	Gross profit N/A	Gross profit ₩81.3b (FY, 2024)	Gross profit zł32.1m (FY, 2021)
Net income	Net income N/A	Net income €5m (FY, 2025)	Net income N/A	Net income (₩5.6b) (FY, 2024)	Net income zł4.3m (FY, 2021)